Margolis Jeff Eliot

Director at RespireRx Pharmaceuticals Inc. · on record since Apr 1, 2013
10% owner at RespireRx Pharmaceuticals Inc. · on record since Mar 24, 2020
SVP, CFO, Secret'y & Treasurer at RespireRx Pharmaceuticals Inc. · on record since Dec 12, 2017

Insider trading activity of Margolis Jeff Eliot

Transactions on record: 102; since Apr 16, 2014

Open-market buys: 0

Open-market sells: 1

Companies traded: 1; last filing Oct 2, 2020

Figures computed from official regulatory filings — .

Companies where Margolis Jeff Eliot has traded

RespireRx Pharmaceuticals Inc.102 tx · Oct 2, 2020

Track record of Margolis Jeff Eliot

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Margolis Jeff Eliot

Co-insiders of Margolis Jeff Eliot

ALLNUTT ROBERTRespireRx Pharmaceuticals Inc.
Attwood James A JrRespireRx Pharmaceuticals Inc.
AURORA CAPITAL CORPRespireRx Pharmaceuticals Inc.
AURORA CAPITAL LLCRespireRx Pharmaceuticals Inc.
BARRON BRUCE NRespireRx Pharmaceuticals Inc.
Battaglia SilvanaRespireRx Pharmaceuticals Inc.
Baumann WernerRespireRx Pharmaceuticals Inc.
Benedik John FRespireRx Pharmaceuticals Inc.
Boratto Eva CRespireRx Pharmaceuticals Inc.
BREUIL ROBERT SRespireRx Pharmaceuticals Inc.
Campbell Elizabeth SRespireRx Pharmaceuticals Inc.
Carley David W.RespireRx Pharmaceuticals Inc.
Carlyle Holdings I GP Sub L.L.C.RespireRx Pharmaceuticals Inc.
Carlyle Realty III, L.P.RespireRx Pharmaceuticals Inc.
Carlyle Realty IV, L.P.RespireRx Pharmaceuticals Inc.
Carlyle Realty V GP, L.L.C.RespireRx Pharmaceuticals Inc.
Carlyle Realty V, L.P.RespireRx Pharmaceuticals Inc.
CASAMENTO CHARLES JRespireRx Pharmaceuticals Inc.
Chizzik StevenRespireRx Pharmaceuticals Inc.
Clark GinaRespireRx Pharmaceuticals Inc.
Cleary James F JRRespireRx Pharmaceuticals Inc.
Clyburn FrankRespireRx Pharmaceuticals Inc.
Cohen Kenneth MRespireRx Pharmaceuticals Inc.
COLEMAN JAMES HRespireRx Pharmaceuticals Inc.
COLLIS STEVEN HRespireRx Pharmaceuticals Inc.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
RespireRx Pharmaceuticals Inc.Listing unverified	Oct 2, 2020	OtherD (derivative)	5,017,144	—	n/a (No price was disclosed in the filing)	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Oct 2, 2020	OtherD (derivative)	150	—	n/a (No price was disclosed in the filing)	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Oct 2, 2020	GiftD (derivative)	-136	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Oct 2, 2020	OtherD (derivative)	91,871,094	—	n/a (No price was disclosed in the filing)	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Oct 2, 2020	Other	5,017,144	—	n/a (No price was disclosed in the filing)	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Oct 2, 2020	Other	91,871,094	—	n/a (No price was disclosed in the filing)	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Oct 2, 2020	GiftD (derivative)	7	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Oct 2, 2020	GiftD (derivative)	-7	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Oct 2, 2020	GiftD (derivative)	7	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Oct 2, 2020	OtherD (derivative)	5,017,144	—	n/a (No price was disclosed in the filing)	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Oct 2, 2020	Other	5,017,144	—	n/a (No price was disclosed in the filing)	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Oct 2, 2020	GiftD (derivative)	136	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Oct 2, 2020	GiftD (derivative)	-7	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Jul 15, 2020	OtherD (derivative)	500	—	n/a (No price was disclosed in the filing)	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Jul 15, 2020	GiftD (derivative)	-25	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Jul 15, 2020	GiftD (derivative)	25	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Jul 15, 2020	GiftD (derivative)	-450	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Jul 15, 2020	GiftD (derivative)	-25	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Jul 15, 2020	GiftD (derivative)	25	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Jul 15, 2020	GiftD (derivative)	450	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Mar 24, 2020	Other	4,500,000	—	n/a (No price was disclosed in the filing)	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Mar 24, 2020	Gift	-125,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Mar 24, 2020	Gift	-125,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Mar 24, 2020	Gift	4,250,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Mar 24, 2020	Gift	-4,250,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
RespireRx Pharmaceuticals Inc.Listing unverified	Oct 2, 2020	OtherD (derivative)	5,017,144	—	n/a (No price was disclosed in the filing)	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Oct 2, 2020	OtherD (derivative)	150	—	n/a (No price was disclosed in the filing)	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Oct 2, 2020	GiftD (derivative)	-136	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Oct 2, 2020	OtherD (derivative)	91,871,094	—	n/a (No price was disclosed in the filing)	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Oct 2, 2020	Other	5,017,144	—	n/a (No price was disclosed in the filing)	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Oct 2, 2020	Other	91,871,094	—	n/a (No price was disclosed in the filing)	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Oct 2, 2020	GiftD (derivative)	7	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Oct 2, 2020	GiftD (derivative)	-7	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Oct 2, 2020	GiftD (derivative)	7	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Oct 2, 2020	OtherD (derivative)	5,017,144	—	n/a (No price was disclosed in the filing)	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Oct 2, 2020	Other	5,017,144	—	n/a (No price was disclosed in the filing)	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Oct 2, 2020	GiftD (derivative)	136	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Oct 2, 2020	GiftD (derivative)	-7	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Jul 15, 2020	OtherD (derivative)	500	—	n/a (No price was disclosed in the filing)	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Jul 15, 2020	GiftD (derivative)	-25	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Jul 15, 2020	GiftD (derivative)	25	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Jul 15, 2020	GiftD (derivative)	-450	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Jul 15, 2020	GiftD (derivative)	-25	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Jul 15, 2020	GiftD (derivative)	25	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Jul 15, 2020	GiftD (derivative)	450	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Mar 24, 2020	Other	4,500,000	—	n/a (No price was disclosed in the filing)	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Mar 24, 2020	Gift	-125,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Mar 24, 2020	Gift	-125,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Mar 24, 2020	Gift	4,250,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Mar 24, 2020	Gift	-4,250,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC